Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis (Q28243702)

Europe PubMed Central

title

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis (English)

1 reference

27 March 2017

0 references

0 references

Stefan H E Kaufmann

1

0 references

Andrew James McMichael

series ordinal

2

object named as

Andrew J McMichael

1 reference

27 March 2017

language of work or name

English

0 references

publication date

April 2005

1 reference

27 March 2017

1 reference

27 March 2017

volume

11

1 reference

27 March 2017

issue

4 Suppl

0 references

4s

1 reference

27 March 2017

page(s)

S33-44

0 references

S33-S44

1 reference

Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin

27 March 2017

cites work

1 reference

Genetics of susceptibility to human infectious disease

21 April 2017

1 reference

Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice

21 April 2017

1 reference

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

21 April 2017

1 reference

Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening

21 April 2017

1 reference

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

21 April 2017

1 reference

The challenge of viral reservoirs in HIV-1 infection

21 April 2017

1 reference

Timing the ancestor of the HIV-1 pandemic strains

21 April 2017

1 reference

The antigenic structure of the HIV gp120 envelope glycoprotein

21 April 2017

1 reference

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

21 April 2017

1 reference

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 April 2017

1 reference

Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program

21 April 2017

1 reference

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

21 April 2017

1 reference

Is the development of a new tuberculosis vaccine possible?

21 April 2017

1 reference

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents

21 January 2018

1 reference

gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

21 January 2018

1 reference

Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections

21 January 2018

1 reference

Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells

21 January 2018

1 reference

Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung

21 January 2018

1 reference

How can immunology contribute to the control of tuberculosis?

21 January 2018

1 reference

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

The immunological aspects of latency in tuberculosis

21 January 2018

1 reference

Mycobacterium bovis BCG response regulator essential for hypoxic dormancy

21 January 2018

1 reference

Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains

21 January 2018

1 reference

Genetic dissection of immunity to mycobacteria: the human model

21 January 2018

1 reference

Iron and microbial infection

21 January 2018

1 reference

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

21 January 2018

1 reference

Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis.

21 January 2018

1 reference

Selecting the components for a safe and efficient tuberculosis subunit vaccine--recent progress and post-genomic insights

21 January 2018

1 reference

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

21 January 2018

1 reference

Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis

21 January 2018

1 reference

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

21 January 2018

1 reference

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

21 January 2018

1 reference

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

21 January 2018

1 reference

Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates

21 January 2018

1 reference

An essential role for phoP in Mycobacterium tuberculosis virulence

21 January 2018

1 reference

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

21 January 2018

1 reference

Comparative genomics of BCG vaccines by whole-genome DNA microarray

21 January 2018

1 reference

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

21 January 2018

1 reference

Bacille Calmette-Guérin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma).

21 January 2018

1 reference

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

21 January 2018

1 reference

HIV-1 dynamics in vivo: implications for therapy

21 January 2018

1 reference

Escape of human immunodeficiency virus from immune control

21 January 2018

1 reference

HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity

21 January 2018

1 reference

HIV preferentially infects HIV-specific CD4+ T cells

21 January 2018

1 reference

HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus

21 January 2018

1 reference

T cell cross-reactivity and conformational changes during TCR engagement

21 January 2018

1 reference

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission

21 January 2018

1 reference

HIV and SIV CTL escape: implications for vaccine design

21 January 2018

1 reference

Reversion of CTL escape–variant immunodeficiency viruses in vivo

21 January 2018

1 reference

Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.

21 January 2018

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients

21 January 2018

1 reference

HIV vaccine design and the neutralizing antibody problem

21 January 2018

1 reference

21 January 2018

1 reference

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

21 January 2018

1 reference

Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins

21 January 2018

1 reference

21 January 2018

HIV vaccine strategies

1 reference

Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data

21 January 2018

1 reference

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting

21 January 2018

1 reference

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

21 January 2018

1 reference

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

21 January 2018

1 reference

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice

21 January 2018

1 reference

CD8+ T cell cross-priming via transfer of proteasome substrates

21 January 2018

1 reference

Antigen bias in T cell cross-priming

21 January 2018

1 reference

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

Mechanisms of protection induced by attenuated simian immunodeficiency virus

21 January 2018

1 reference

Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates

21 January 2018

1 reference

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

21 January 2018

1 reference

Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.

21 January 2018

1 reference

HIV-1/AIDS and the control of other infectious diseases in Africa

21 January 2018

1 reference

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

Boosting vaccine for tuberculosis

21 January 2018

1 reference

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

21 January 2018

1 reference

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

21 January 2018

1 reference

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques

21 January 2018

1 reference

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

21 January 2018

1 reference

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

21 January 2018

1 reference

Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review

21 January 2018

1 reference

12 December 2020

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

12 December 2020

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses

1 reference

12 December 2020

Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.

1 reference

12 December 2020

Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin

1 reference

12 December 2020

In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production

1 reference

12 December 2020

Molecular determinants of Listeria monocytogenes pathogenesis

1 reference

12 December 2020

HIV escape: there and back again

1 reference

12 December 2020

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

1 reference

12 December 2020

Auxotrophic vaccines for tuberculosis

1 reference

12 December 2020

Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study

1 reference

12 December 2020

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development

1 reference

12 December 2020

Recent advances in understanding the molecular mechanisms of HIV-1 entry and fusion: revisiting current targets and considering new options for therapeutic intervention

1 reference

12 December 2020

The pathogenesis of sexual mucosal transmission and early stages of infection: obstacles and a narrow window of opportunity for prevention

1 reference

12 December 2020

The BCG story: lessons from the past and implications for the future

1 reference

12 December 2020

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

12 December 2020

Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity

1 reference

12 December 2020

Type I interferons promote cross-priming: more functions for old cytokines

1 reference

12 December 2020

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

12 December 2020

Prospects for an AIDS vaccine

1 reference

12 December 2020

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

12 December 2020

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM1221

2 references

27 March 2017

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

15812488

1 reference

Consolidated OpenCitations Corpus – April 2017